Valuation: Biogen Inc.

Market Cap 30.78B 26.95B 24.83B 23.04B 43.76B 2,936B 44.35B 297B 116B 1,441B 116B 113B 4,996B P/E 2026 *
31.8x
P/E 2027 * 17.5x
Enterprise Value 36.21B 31.71B 29.21B 27.11B 51.48B 3,454B 52.18B 350B 136B 1,695B 136B 133B 5,878B EV / Sales 2026 *
3.6x
EV / Sales 2027 * 3.28x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-3.54%
1 week-3.77%
Current month-3.52%
1 month+6.72%
3 months+20.96%
6 months+14.16%
Current year+18.45%
1 week 208.27
Extreme 208.27
219.02
1 month 192.18
Extreme 192.18
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
282.74
5 years 110.04
Extreme 110.035
372.12
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-3.54%-3.77%+56.89%-26.85% 30.78B
-0.68%+2.85%+18.72%-7.81% 66.11B
-1.97%-3.45%+50.62%+221.13% 55.3B
-1.13%+40.50%+40.50%+40.50% 42.44B
+0.23%+8.52%-49.79%-53.35% 41.28B
+2.56%+17.36%+168.28%-30.85% 32.46B
-1.06%+0.84%+68.91%+83.93% 23.1B
-3.65%+9.61%+5.69%+188.43% 20.06B
+0.21%+3.76%+66.67%+133.69% 17.19B
+0.73%+7.97%+76.74%+357.35% 15.23B
Average -0.82%+5.51%+50.32%+90.62% 34.39B
Weighted average by Cap. -0.87%+4.22%+43.42%+66.46%

Financials

2026 *2027 *
Net sales 10.06B 8.81B 8.11B 7.53B 14.3B 959B 14.49B 97.09B 37.79B 471B 37.76B 36.93B 1,632B 10.38B 9.09B 8.38B 7.77B 14.76B 990B 14.96B 100B 39.02B 486B 38.99B 38.14B 1,686B
Net income 1.52B 1.33B 1.23B 1.14B 2.16B 145B 2.19B 14.7B 5.72B 71.27B 5.72B 5.59B 247B 1.97B 1.72B 1.59B 1.47B 2.8B 188B 2.84B 19.01B 7.4B 92.19B 7.39B 7.23B 320B
Net Debt 5.43B 4.76B 4.38B 4.07B 7.72B 518B 7.82B 52.43B 20.4B 254B 20.39B 19.94B 881B 3.31B 2.9B 2.67B 2.48B 4.71B 316B 4.77B 31.96B 12.44B 155B 12.43B 12.16B 537B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
06/07/26 USD 208.46 -3.54% 1,218,492
02/07/26 USD 216.12 +3.04% 1,155,165
01/07/26 USD 209.74 -2.93% 1,138,639
30/06/26 USD 216.06 -0.26% 1,091,325
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
208.46USD
Average target price
221.96USD
Spread / Average Target
+6.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock